临床试验中有序复合终点使用胜出时间的应用
该文针对测量多个临床事件首次发生时间的临床试验,提出若干胜出比新变体,将各临床状态所经历的时间纳入整体治疗获益评估,并允许将随访期间死亡设为最重要。模拟显示,当死亡方面的整体治疗获益较大时,基于预期胜出时间或估计临床状态分布的变体检验效能显著高于成对比较或复合事件法;方法通过心力衰竭运动训练试验再分析进行展示。
要点
- 新胜出比变体将各临床状态所经历的时间纳入整体治疗获益评估。
- 其中一个变体允许将随访期间死亡设为最重要,同时仍计入其他状态时间。
- 模拟显示死亡获益较大时,基于预期胜出时间或状态分布的变体检验效能更高。
核心结论
- 新方法旨在比普通胜出比更贴近患者视角的整体治疗获益或危害。
- 模拟显示当死亡方面的整体治疗获益较大时,基于预期胜出时间或估计临床状态分布的变体检验效能显著高于成对比较或复合事件法。
研究设计与样本
- 方法学文章,描述胜出比的若干新变体并采用模拟比较,通过再分析心力衰竭运动训练试验进行展示。
主要发现
- 描述了一个允许将随访期间死亡设为最重要、同时仍计入其他临床状态时间的胜出比变体。
- 另三种变体分别基于平均成对胜出时间、基于对参考分布的预期胜出时间为每名参与者构建连续结局、以及利用估计的临床状态分布比较治疗组。
- 描述了一种组合检验方法,旨在跨广泛备择假设为检测治疗获益提供稳健的检验效能。
- 模拟显示当死亡方面的整体治疗获益较大时,基于预期胜出时间或估计临床状态分布的变体检验效能显著高于成对比较或复合事件法。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Consider the choice of outcome for overall treatment benefit in a clinical trial which measures the first time to each of several clinical events. We describe several new variants of the win ratio that incorporate the time spent in each clinical state over the common follow-up, where clinical state means the worst clinical event that has occurred by that time. One version allows restriction so that death during follow-up is most important, while time spent in other clinical states is still accounted for. Three other variants are described; one is based on the average pairwise win time, one creates a continuous outcome for each participant based on expected win times against a reference distribution and another that uses the estimated distributions of clinical state to compare the treatment arms. Finally, a combination testing approach is described to give robust power for detecting treatment benefit across a broad range of alternatives. These new methods are designed to be closer to the overall treatment benefit/harm from a patient's perspective, compared to the ordinary win ratio. The new methods are compared to the composite event approach and the ordinary win ratio. Simulations show that when overall treatment benefit on death is substantial, the variants based on either the participants' expected win times (EWTs) against a reference distribution or estimated clinical state distributions have substantially higher power than either the pairwise comparison or composite event methods. The methods are illustrated by re-analysis of the trial heart failure: a controlled trial investigating outcomes of exercise training.
引用
- Troendle JF, Leifer ES, Yang S, et al. Use of win time for ordered composite endpoints in clinical trials. Stat Med. 2024. PMID: 38417455. doi:10.1002/sim.10045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。